Min Kyung Jin, Lee Yoon Jae, Suh Mina, Yoo Chong Woo, Lim Myong Cheol, Choi Jaekyung, Ki Moran, Kim Yong Man, Kim Jae Weon, Kim Jea Hoon, Park Eal Whan, Lee Hoo Yeon, Lim Sung Chul, Cho Chi Heum, Hong Sung Ran, Dang Ji Yeon, Kim Soo Young, Kim Yeol, Lee Won Chul, Lee Jae Kwan
Department of Obstetrics and Gynecology, Korea University Medical Center, Seoul, Korea.
Department of Korean Gynecology, Jaseng Hospital of Korean Medicine, Seoul, Korea.
J Gynecol Oncol. 2015 Jul;26(3):232-9. doi: 10.3802/jgo.2015.26.3.232.
The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass-screening program. Furthermore, a new method has been introduced in cervical cancer screening. Therefore, the committee for cervical cancer screening in Korea updated the recommendation statement established in 2002. The new version of the guideline was developed by the committee using evidence-based methods. The committee reviewed the evidence for the benefits and harms of the Papanicolaou test, liquid-based cytology, and human papillomavirus (HPV) testing, and reached conclusions after deliberation. The committee recommends screening for cervical cancer with cytology (Papanicolaou test or liquid-based cytology) every three years in women older than 20 years of age (recommendation A). The cervical cytology combined with HPV test is optionally recommended after taking into consideration individual risk or preference (recommendation C). The current evidence for primary HPV screening is insufficient to assess the benefits and harms of cervical cancer screening (recommendation I). Cervical cancer screening can be terminated at the age of 74 years if more than three consecutive negative cytology reports have been confirmed within 10 years (recommendation D).
尽管韩国实施了全国性的大规模筛查计划，但其宫颈癌发病率仍高于其他发达国家。此外，宫颈癌筛查引入了一种新方法。因此，韩国宫颈癌筛查委员会更新了2002年制定的推荐声明。该委员会采用循证方法制定了新版指南。委员会审查了巴氏试验、液基细胞学检查和人乳头瘤病毒（HPV）检测的利弊证据，并经过审议得出结论。委员会建议20岁以上女性每三年进行一次细胞学（巴氏试验或液基细胞学检查）宫颈癌筛查（推荐A）。考虑个体风险或偏好后，可选择推荐宫颈细胞学检查联合HPV检测（推荐C）。目前关于原发性HPV筛查的证据不足以评估宫颈癌筛查的利弊（推荐I）。如果在10年内连续三次以上细胞学报告为阴性，则宫颈癌筛查可在74岁时终止（推荐D）。
